IndraLab

Statements


| 4

reach
"In present study treatment with ursolic acid found to inhibit the NF-κB p50, NF-κB p65, NF-κBc-Rel, c-Fos, ATF-2 and CREB significantly ( p < 0.001) in B16F-10 melanoma cells."

reach
"The anti-inflammatory, anticarcinogenic, and proapoptotic activities of ursolic acid could be correlated to its potential to inhibit the immunoregulatory transcription factor NFkB in carcinogens and inflammatory responses (Checker etal.,2012; Shishodia etal.,2003)."

reach
"Recently, several in vitro studies have indicated that ursolic acid inhibits NFkB activation through suppression of IkBalpha kinase and p65 phosphorylation (Shishodia et al., 2003; Zeng et al., 2011) [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"

reach
"Ursolic acid treatment downregulated the gene expression of survival factors BCL-2, SURVIVIN, NFKB and SP1, while upregulated the growth restricting genes BAX, P21 and P53."